STOCK TITAN

[8-K] Vivakor, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Vivakor, Inc. completed a registered direct offering, selling 8,417,645 shares of common stock at $0.2164 per share and 14,689,851 pre-funded warrants at $0.2154, for aggregate gross proceeds of approximately $5 million before fees. The transaction closed on October 17, 2025.

The pre-funded warrants are immediately exercisable at $0.001 per share and include ownership limits of 4.99% (or 9.99% if elected before issuance). Vivakor plans to use net proceeds for working capital and general corporate purposes. D. Boral Capital LLC acted as placement agent, receiving a 7% cash fee, a 1% non-accountable expense fee, and reimbursed expenses. The securities were offered off the company’s effective Form S-3 shelf and a prospectus supplement dated October 16, 2025.

Vivakor, Inc. ha completato un'offerta diretta registrata, vendendo 8.417.645 azioni ordinarie a 0,2164 $ per azione e 14.689.851 warrant prefinanziati a 0,2154 $, per proventi lordi aggregati di circa 5 milioni di dollari prima delle commissioni. La transazione si è chiusa il 17 ottobre 2025.

I warrant prefinanziati sono immediatamente esercitabili a 0,001 $ per azione e prevedono limiti di proprietà del 4,99% (oppure 9,99% se scelti prima dell’emissione). Vivakor intende utilizzare i proventi netti per capitale circolante e scopi aziendali generali. D. Boral Capital LLC ha agito come agente di collocamento, ricevendo una commissione in contanti del 7%, una commissione spese non contabilizzate dell'1% e spese rimborsate. Le securità sono state offerte al di fuori della shelf effettiva Form S-3 della società e di un supplemento di prospetto datato 16 ottobre 2025.

Vivakor, Inc. completó una oferta directa registrada, vendiendo 8,417,645 acciones comunes a 0,2164 $ por acción y 14,689,851 warrants prefinanciados a 0,2154 $, por ingresos brutos agregados de aproximadamente 5 millones de dólares antes de comisiones. La transacción se cerró el 17 de octubre de 2025.

Los warrants prefinanciados son ejercitables de inmediato a 0,001 $ por acción e incluyen límites de propiedad del 4,99% (o 9,99% si se eligió antes de la emisión). Vivakor planea usar los ingresos netos para capital de trabajo y para fines corporativos generales. D. Boral Capital LLC actuó como agente de colocación, recibiendo una comisión en efectivo del 7%, una comisión de gastos no auditable del 1% y gastos reembolsados. Los valores se ofrecieron fuera del shelf efectivo de Form S-3 de la empresa y de un suplemento de prospecto fechado el 16 de octubre de 2025.

Vivakor, Inc.은 등록 직접 공모를 완료했고, 보통주 8,417,645주를 주당 0.2164달러에, 선지급 워런트 14,689,851주를 주당 0.2154달러에 팔아 수익 총액이 수수료 전 약 500만 달러에 달했습니다. 거래는 2025년 10월 17일에 마감되었습니다.

선지급 워런트는 주당 0.001달러의 즉시 행사 가능하며, 소유 한도는 4.99%(발행 전에 선택 시 9.99%)를 포함합니다. Vivakor는 순수익을 운용 자본 및 일반 기업 용도로 사용할 계획입니다. D. Boral Capital LLC는 배치 에이전트로 활동하며 현금 수수료 7%, 비계정 가능 비용 수수료 1%, 및 상환 비용을 수령했습니다. 증권은 회사의 유효 Form S-3 셀프 또는 2025년 10월 16일자의 투자설명서 보충서에 따라 제안되었습니다.

Vivakor, Inc. a finalisé une offre directe enregistrée, vendant 8 417 645 actions ordinaires à 0,2164 $ par action et 14 689 851 warrants pré-financés à 0,2154 $, pour des produits bruts agrégés d’environ 5 millions de dollars avant frais. La transaction a été clôturée le 17 octobre 2025.

Les warrants pré-financés sont immédiatement exerçables à 0,001 $ par action et comportent des limites de propriété de 4,99 % (ou 9,99 % si choisi avant l’émission). Vivakor prévoit d’utiliser le produit net pour les besoins de fonds de roulement et les fins générales de l’entreprise. D. Boral Capital LLC a agi en tant qu’agent de placement, recevant une commission en espèces de 7 %, une commission de frais non comptabilisés de 1 % et des frais remboursables. Les titres ont été offerts hors du shelf Form S-3 de la société et d’un supplément de prospectus daté du 16 octobre 2025.

Vivakor, Inc. hat ein registriertes Direct Offering abgeschlossen und 8.417.645 Stammaktien zu je 0,2164 $ pro Aktie sowie 14.689.851 Vorfinanzierungs-Warrants zu je 0,2154 $ verkauft, was Bruttoemittenten-Erlöse von ca. 5 Mio. $ vor Gebühren ergibt. Der Abschluss der Transaktion erfolgte am 17. Oktober 2025.

Die Vorfinanzierungs-Warrants sind sofort zu 0,001 $ pro Aktie ausübbar und enthalten Eigentumsgrenzen von 4,99 % (bzw. 9,99 %, wenn vor der Ausgabe gewählt). Vivakor plant, den Nettobetrag für Betriebskapital und allgemeine Unternehmenszwecke zu verwenden. D. Boral Capital LLC fungierte als Platzierungsagent und erhielt eine Barprovision von 7 %, eine 1 %-ige nicht abrechnungsfähige Spesenpauschale sowie erstattete Ausgaben. Die Wertpapiere wurden außerhalb des effektiven Form S-3-Regals der Gesellschaft und eines Prospektzusatzes vom 16. Oktober 2025 angeboten.

Vivakor, Inc. أكملت عرضاً مباشراً مسجلاً، حيث باعت 8,417,645 سهماً عادياً بسعر 0.2164 دولار للسهم و14,689,851 من الضمانات المسبقة التمويل بسعر 0.2154 دولار، بإجمالي عوائد إجمالية تقارب 5 ملايين دولار قبل الرسوم. أغلق الصفقة في 17 أكتوبر 2025.

تكون الضمانات المسبقة التمويل قابلة للممارسة فوراً بسعر 0.001 دولار للسهم وتتضمن حدود ملكية تبلغ 4.99% (أو 9.99% إذا تم الاختيار قبل الإصدار). تخطط Vivakor لاستخدام صافي العوائد لرأس المال العامل ول لغرضات الشركة العامة. عملت D. Boral Capital LLC كوكيل للطرح، وحصلت على عمولة نقدية قدرها 7%، وعمولة مصروفات غير قابلة للمحاسبة قدرها 1%، وتكاليف معاد تحملها. وتم عرض الأوراق المالية خارج رف Form S-3 الفعّال للشركة ومُلحق نشرة الإصدار المؤرّخ 16 أكتوبر 2025.

Vivakor, Inc. 已完成一项注册直接发行,出售8,417,645股普通股,价格为每股0.2164美元,以及14,689,851份前资金认股权证,价格为每份0.2154美元,总毛额融资约为500万美元(未扣除费用)。交易于2025年10月17日完成。

前资金认股权证可立即按每股0.001美元行使,所有权上限为4.99%(若在发行前选择则为9.99%)。Vivakor计划将净收益用于运营资金和公司一般用途。D. Boral Capital LLC担任配售代理,获得7%的现金佣金、1%的不可核销费用以及报销的费用。该等证券是在公司有效的Form S-3架构及日期为2025年10月16日的招股说明书补充文件下发行。

Positive
  • None.
Negative
  • None.

Insights

Primary equity raise of about $5,000,000 with pre-funded warrants.

Vivakor executed a registered direct offering, issuing 8,417,645 shares at $0.2164 and 14,689,851 pre-funded warrants at $0.2154, for gross proceeds of about $5,000,000. Pre-funded warrants are immediately exercisable at $0.001 per share, a common structure to minimize ongoing exercise cost.

The warrants include a Beneficial Ownership Limitation of 4.99% (or 9.99% if elected prior to issuance), which can moderate instantaneous ownership concentration. Cash fees include a 7% placement fee and 1% non-accountable expense, plus reimbursed costs to the placement agent.

Use of proceeds is for working capital and general corporate purposes. The deal closed on October 17, 2025 under an effective S-3 shelf using a October 16, 2025 prospectus supplement.

Vivakor, Inc. ha completato un'offerta diretta registrata, vendendo 8.417.645 azioni ordinarie a 0,2164 $ per azione e 14.689.851 warrant prefinanziati a 0,2154 $, per proventi lordi aggregati di circa 5 milioni di dollari prima delle commissioni. La transazione si è chiusa il 17 ottobre 2025.

I warrant prefinanziati sono immediatamente esercitabili a 0,001 $ per azione e prevedono limiti di proprietà del 4,99% (oppure 9,99% se scelti prima dell’emissione). Vivakor intende utilizzare i proventi netti per capitale circolante e scopi aziendali generali. D. Boral Capital LLC ha agito come agente di collocamento, ricevendo una commissione in contanti del 7%, una commissione spese non contabilizzate dell'1% e spese rimborsate. Le securità sono state offerte al di fuori della shelf effettiva Form S-3 della società e di un supplemento di prospetto datato 16 ottobre 2025.

Vivakor, Inc. completó una oferta directa registrada, vendiendo 8,417,645 acciones comunes a 0,2164 $ por acción y 14,689,851 warrants prefinanciados a 0,2154 $, por ingresos brutos agregados de aproximadamente 5 millones de dólares antes de comisiones. La transacción se cerró el 17 de octubre de 2025.

Los warrants prefinanciados son ejercitables de inmediato a 0,001 $ por acción e incluyen límites de propiedad del 4,99% (o 9,99% si se eligió antes de la emisión). Vivakor planea usar los ingresos netos para capital de trabajo y para fines corporativos generales. D. Boral Capital LLC actuó como agente de colocación, recibiendo una comisión en efectivo del 7%, una comisión de gastos no auditable del 1% y gastos reembolsados. Los valores se ofrecieron fuera del shelf efectivo de Form S-3 de la empresa y de un suplemento de prospecto fechado el 16 de octubre de 2025.

Vivakor, Inc.은 등록 직접 공모를 완료했고, 보통주 8,417,645주를 주당 0.2164달러에, 선지급 워런트 14,689,851주를 주당 0.2154달러에 팔아 수익 총액이 수수료 전 약 500만 달러에 달했습니다. 거래는 2025년 10월 17일에 마감되었습니다.

선지급 워런트는 주당 0.001달러의 즉시 행사 가능하며, 소유 한도는 4.99%(발행 전에 선택 시 9.99%)를 포함합니다. Vivakor는 순수익을 운용 자본 및 일반 기업 용도로 사용할 계획입니다. D. Boral Capital LLC는 배치 에이전트로 활동하며 현금 수수료 7%, 비계정 가능 비용 수수료 1%, 및 상환 비용을 수령했습니다. 증권은 회사의 유효 Form S-3 셀프 또는 2025년 10월 16일자의 투자설명서 보충서에 따라 제안되었습니다.

Vivakor, Inc. a finalisé une offre directe enregistrée, vendant 8 417 645 actions ordinaires à 0,2164 $ par action et 14 689 851 warrants pré-financés à 0,2154 $, pour des produits bruts agrégés d’environ 5 millions de dollars avant frais. La transaction a été clôturée le 17 octobre 2025.

Les warrants pré-financés sont immédiatement exerçables à 0,001 $ par action et comportent des limites de propriété de 4,99 % (ou 9,99 % si choisi avant l’émission). Vivakor prévoit d’utiliser le produit net pour les besoins de fonds de roulement et les fins générales de l’entreprise. D. Boral Capital LLC a agi en tant qu’agent de placement, recevant une commission en espèces de 7 %, une commission de frais non comptabilisés de 1 % et des frais remboursables. Les titres ont été offerts hors du shelf Form S-3 de la société et d’un supplément de prospectus daté du 16 octobre 2025.

Vivakor, Inc. hat ein registriertes Direct Offering abgeschlossen und 8.417.645 Stammaktien zu je 0,2164 $ pro Aktie sowie 14.689.851 Vorfinanzierungs-Warrants zu je 0,2154 $ verkauft, was Bruttoemittenten-Erlöse von ca. 5 Mio. $ vor Gebühren ergibt. Der Abschluss der Transaktion erfolgte am 17. Oktober 2025.

Die Vorfinanzierungs-Warrants sind sofort zu 0,001 $ pro Aktie ausübbar und enthalten Eigentumsgrenzen von 4,99 % (bzw. 9,99 %, wenn vor der Ausgabe gewählt). Vivakor plant, den Nettobetrag für Betriebskapital und allgemeine Unternehmenszwecke zu verwenden. D. Boral Capital LLC fungierte als Platzierungsagent und erhielt eine Barprovision von 7 %, eine 1 %-ige nicht abrechnungsfähige Spesenpauschale sowie erstattete Ausgaben. Die Wertpapiere wurden außerhalb des effektiven Form S-3-Regals der Gesellschaft und eines Prospektzusatzes vom 16. Oktober 2025 angeboten.

false 0001450704 0001450704 2025-10-16 2025-10-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 16, 2025

 

VIVAKOR, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-41286   26-2178141
(State or other jurisdiction of   (Commission   (IRS Employer
incorporation or organization)   File Number)   Identification No.)

 

5220 Spring Valley Road, Suite 500

Dallas, TX 75254

(Address of principal executive offices)

 

(949) 281-2606

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   VIVK   The Nasdaq Stock Market LLC (Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

 

 

Item 1.01 Entry Into Material Definitive Agreement.

 

On October 16, 2025, Vivakor, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a registered direct offering (A) an aggregate of 8,417,645 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company, at an offering price of $0.2164 per share, and (B) 14,689,851 pre-funded warrants (the “Pre-Funded Warrants”) in lieu of shares of Common Stock, at an offering price of $0.2154 (such registered direct offering, the “Offering”) for aggregate gross proceeds of approximately $5 million, before deducting Offering expenses payable by the Company, including the Placement Agent’s commissions and fees. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes. The Offering closed on October 17, 2025.

 

The Pre-Funded Warrants are immediately exercisable and may be exercised at a nominal consideration of $0.001 per share of Common Stock at any time until all of the Pre-Funded Warrants are exercised in full.

 

The Pre-Funded Warrants contain ownership limitations pursuant to which a holder does not have the right to exercise any portion of their warrants if it would result in the holder (together with its affiliates) beneficially owning more than 4.99% (or, upon election by the holder prior to the issuance of any warrants, 9.99%) of the Company’s outstanding Common Stock.

 

In connection with the Offering, the Company also entered into a placement agency agreement (the “Placement Agency Agreement”) with D. Boral Capital LLC (the “Placement Agent”), pursuant to which the Company paid the Placement Agent (i) a cash fee equal to 7% of the aggregate gross proceeds of the Offering, (ii) one percent (1.0%) of the gross proceeds of the Offering for non-accountable expenses, and (iii) reimbursed the Placement Agent for certain expenses and legal fees.

 

The Common Shares, the Pre-Funded Warrants and the shares of Common Stock underlying the Pre-Funded Warrants were offered pursuant to a “shelf” registration statement on Form S-3 (File No. 333-269178) that was declared effective by the Securities and Exchange Commission (the “Commission”) on February 10, 2023 and a prospectus supplement dated October 16, 2025, which was filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended.

 

The Purchase Agreement, the Placement Agency Agreement and form of the Pre-Funded Warrant are filed as exhibits to this Current Report on Form 8-K (this “Form 8-K”) and are incorporated by reference herein.

 

ITEM 8.01 Other Events.

 

On October 16, 2025, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

 

 1 

 

 

ITEM 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Title
4.1   Form of Pre-Funded Warrant
5.1   Legal Opinion of Lucosky Brookman LLP
10.1   Form of Securities Purchase Agreement
10.2   Form of Placement Agency Agreement
99.1   Press Release, dated October 16, 2025
104   Cover Page Interactive Data File (formatted as Inline XBRL).

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIVAKOR, INC.
     
Dated: October 17, 2025 By: /s/ James H. Ballengee
    Name: James H. Ballengee
    Title: Chairman, President & CEO

 

 3 

FAQ

What did VIVK sell in the registered direct offering?

Vivakor sold 8,417,645 shares at $0.2164 and 14,689,851 pre-funded warrants at $0.2154.

How much did VIVK raise in gross proceeds?

The offering generated approximately $5 million in gross proceeds before fees and expenses.

What is the exercise price of the pre-funded warrants?

The pre-funded warrants are immediately exercisable at $0.001 per share.

Are there ownership limits on exercising the pre-funded warrants?

Yes. Holders are limited to 4.99% (or 9.99% if elected before issuance) beneficial ownership.

What will VIVK use the net proceeds for?

Vivakor intends to use net proceeds for working capital and general corporate purposes.

Who was the placement agent and what were the fees?

D. Boral Capital LLC; fees included 7% of gross proceeds, 1% non-accountable expenses, plus reimbursed expenses.

Under what registration was the offering made?

The securities were offered under an effective Form S-3 shelf and a prospectus supplement dated October 16, 2025.
Vivakor

NASDAQ:VIVK

VIVK Rankings

VIVK Latest News

VIVK Latest SEC Filings

VIVK Stock Data

17.33M
22.07M
54.06%
10.47%
0.32%
Oil & Gas Integrated
Refuse Systems
Link
United States
DALLAS